Clinical trial
Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
NCT02200705 is registered in ClinicalTrials.gov with IceCure Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
- Lead sponsor
- IceCure Medical Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- May 26, 2024
- Enrollment
- 206 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer